Related Experiment Video
Updated: Apr 5, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
7.0K
Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma
Pranav Sharma1, Einar F Sverrisson, Kamran Zargar-Shoshtari
1Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
The Canadian Journal of Urology
|August 13, 2015
Summary
Post-chemotherapy minimally-invasive retroperitoneal lymph node dissection (MI-RPLND) is a viable treatment for select nonseminoma patients with residual masses. This approach showed acceptable morbidity and no short-term recurrence in the study group.
Area of Science:
- Oncology
- Surgical Oncology
- Urologic Oncology
Background:
- Nonseminoma germ cell tumors often require post-chemotherapy treatment for residual masses.
- Minimally-invasive retroperitoneal lymph node dissection (MI-RPLND) offers a less invasive surgical option.
Purpose of the Study:
- To evaluate the feasibility and outcomes of MI-RPLND in patients with nonseminoma residual masses after chemotherapy.
- To assess patient morbidity and short-term oncologic outcomes.
Main Methods:
- Retrospective review of 19 patients undergoing post-chemotherapy MI-RPLND (laparoscopic or robotic) for low-volume residual disease.
- Data collected included clinicodemographic information, operative details, and pathological outcomes.
Main Results:
- The median age was 32, with 63% presenting with clinical stage II disease.
- Median residual mass size was 2.1 cm; 42% of patients had residual teratoma on pathology.
- No recurrences were observed at a median follow-up of 24 months, with low-grade complications (Clavien grade II or less).
Conclusions:
- Post-chemotherapy MI-RPLND is a feasible surgical option for carefully selected nonseminoma patients.
- The procedure demonstrated acceptable morbidity and promising short-term oncologic outcomes.
- Longer follow-up is necessary to confirm the long-term efficacy of this approach.
